Soluble Tumor Necrosis Factor ? Receptor Prevents Decrease of Body Temperature in Mice Treated with Indomethacin and Lipopolysaccharide
- 1 March 1997
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 813 (1 Thermore) , 264-271
- https://doi.org/10.1111/j.1749-6632.1997.tb51704.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effect of physiological ADP concentrations on contraction of single skinned fibers from rabbit fast and slow musclesAmerican Journal of Physiology-Cell Physiology, 1995
- Prostaglandin E2 inhibits the release of tumor necrosis factor-α, rather than interleukin 1β, from human macrophagesImmunology Letters, 1992
- Differential activities of site specific lipoxygenase inhibitors in endotoxic shock and production of tumor necrosis factor αInternational Journal of Immunopharmacology, 1991
- Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents.The Journal of Experimental Medicine, 1991
- Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.The Journal of Experimental Medicine, 1989
- Thermoregulatory Actions of Eicosanoids in the Central Nervous System with Particular Regard to the Pathogenesis of FeverAnnals of the New York Academy of Sciences, 1989
- Lipoxygenase inhibitors suppress formation of tumor necrosis factor in, vitro and in, vivoBiochemical and Biophysical Research Communications, 1989
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- Regulation of macrophage tumor necrosis factor production by prostaglandin E2Biochemical and Biophysical Research Communications, 1986